Open Letter from CEO, Bill Newell

Open Letter from CEO, Bill Newell Today, I want to clearly state, that America still has a very long way to go to fulfill the hard won promises of the Civil Rights era of the 60s. I was born in 1957 and so was first exposed to civil rights issues as a child. But I was...

Bristol Myers Squibb Investor Series

Bristol Myers Squibb Investor Series Bristol Myers Squibb Investor Series - Hematology June 25, 2020 at 11:30am ET WEBCAST View This Presentation   Bristol Myers Squibb Investor Series - Early Pipeline and Immuno-Oncology June 22, 2020 at 11:30am ET WEBCAST View...

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity Additionally, Sutro’s...